853029-57-9 8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-xanthine 98%

We are located at Indian Pharmaceutical hub of Hyderabad.    The R&D is well equipped to run all types of chemical reactions like cryo reactions, hydrogenations, high temperature reactions etc.    HPLC, GC and other associated instruments are available in AR&D.

We take up extensive process research and development right from route selection, process research using QbD approaches and ICH Q11, gentoxic evaluations as per ICH M7, control strategy, Product development reports, process safety evaluations, scale-up/ pilot plant trials, analytical method validations.    Technology transfer to the GMP locations, Process validations, DMF filings, regulatory responses and commercial manufacturing.    We provide the services & Strategic partnership for development, Validations, DMF filing and commercial manufacturing of APIs and Intermediates of APIs.    We are flexible in our business model to support various clients.

Dr. B. Sreenivasa Rao, is the Key promoter of the organisation and holding the role of whole time Director and Chief Executive Officer.
Dr. Rao has a Ph.D. in Chemistry and having a rich experience of over 23 years in the pharmaceutical industry with expertise in drug discovery research, process research, development of Active Pharmaceutical Ingredients (APIs), New Chemical Entities (NCEs), custom chemical synthesis, contract research and manufacturing.   He has the experience of working with multiple customers spread across various geographies both in India and abroad.   He has worked with some leading and marque customers based in USA, Europe, Japan, Israel and supported their critical projects.